These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25671237)

  • 1. Retraction notice to "3-Benzhydryl-4-piperidones as novel neurokinin-1 receptor antagonists and their efficient synthesis" [Bioorg. Med. Chem. 19 (2011) 5175-82].
    Bioorg Med Chem; 2015 Jan; 23(1):272. PubMed ID: 25671237
    [No Abstract]   [Full Text] [Related]  

  • 2. Retraction notice to 'Corrigendum to "3-Benzhydryl-4-piperidones as novel neurokinin-1 receptor antagonists and their efficient synthesis"' [Bioorg. Med. Chem. 20 (2012) 5668-5668].
    Bioorg Med Chem; 2014 Dec; 22(23):6726. PubMed ID: 25756091
    [No Abstract]   [Full Text] [Related]  

  • 3. 3-benzhydryl-4-piperidones as novel neurokinin-1 receptor antagonists and their efficient synthesis.
    Shirai J; Yamaoka M; Imamiya E; Nakamura M; Tarui N; Hashimoto T; Ikeura Y
    Bioorg Med Chem; 2011 Sep; 19(17):5175-82. PubMed ID: 21807525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retraction notice to "Sannastatin, a novel toxic macrolactam polyketide glycoside produced by actinomycete Streptomyces sannanensis" [Bioorg. Med. Chem. Lett. 21 (2011) 3905-3908].
    Yang SX; Gao JM; Zhang AL; Laatsch H
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4219. PubMed ID: 28826506
    [No Abstract]   [Full Text] [Related]  

  • 5. Retraction notice to "Design, synthesis, structure-activity relationship and kinase inhibitory activity of substituted 3-methyl-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-ones" [Bioorg. Med. Chem. Lett. 26 (2016) 3093-3097].
    Lamie PF
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4220. PubMed ID: 28826507
    [No Abstract]   [Full Text] [Related]  

  • 6. Retraction notice to 'Design and synthesis of CHAP31, trapoxin B and HC-toxin based bicyclic tetrapeptides disulfide as potent histone deacetylase inhibitors' [Bioorg Med Chem 22 (2014) 3850-3855].
    Bioorg Med Chem; 2015 Aug; 23(15):5078. PubMed ID: 26425745
    [No Abstract]   [Full Text] [Related]  

  • 7. Retraction notice to "Synthesis and bioevaluation of aryl-guanidino polyamine conjugates targeting the polyamine transporter" [Bioorg. Med. Chem. Lett. 20 (2010) 6421-6425].
    Wang J; Chen Z; Xie S; Zhao J; Wang C
    Bioorg Med Chem Lett; 2021 Sep; 47():128251. PubMed ID: 34256984
    [No Abstract]   [Full Text] [Related]  

  • 8. Retraction notice to "Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrug of 5-aminosalicylic acid with D-phenylalanine for colon specific drug delivery in inflammatory bowel disease" [Bioorg. Med. Chem. Lett. 17 (2007) 1897-1902].
    Bioorg Med Chem Lett; 2009 Feb; 19(3):1035. PubMed ID: 19434916
    [No Abstract]   [Full Text] [Related]  

  • 9. Retraction notice to "Colon-specific, mutual azo prodrug of 5-aminosalicylic acid with L-tryptophan: synthesis, kinetic studies and evaluation of its mitigating effect in trinitrobenzenesulfonic acid-induced colitis in rats" [Bioorg. Med. Chem. 17 (2007) 15 (2007) 4903-4909].
    Dhaneshwar SS; Gairola N; Kandpal M; Vadnerkar G; Bhatt L
    Bioorg Med Chem; 2009 Jan; 17(2):930. PubMed ID: 19177601
    [No Abstract]   [Full Text] [Related]  

  • 10. Retraction notice to "A computational docking study for prediction of binding mode of diospyrin and derivatives: Inhibitors of human and leishmanial DNA topoisomerase-I" [Bioorg. Med. Chem. Lett. 17 (2007) 4604-4612].
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5281. PubMed ID: 17987674
    [No Abstract]   [Full Text] [Related]  

  • 11. Retraction notice to "Preclinical metabolism of LB42908, a novel farnesyl transferase inhibitor, and its effects on the cytochrome P450 isozyme activities" [Bioorg. Med. Chem. Lett. 22(9) (2012) 3067-3071].
    Chang M; Lee SH; Kim HJ; Koh JS; Kim A
    Bioorg Med Chem Lett; 2024 May; 104():129734. PubMed ID: 38604924
    [No Abstract]   [Full Text] [Related]  

  • 12. Retraction notice to "Carboxylated calixarenes bind strongly to CD69 and protect CD69(+) killer cells from suicidal cell death induced by tumor cell surface ligands" [Bioorg. Med. Chem. 18 (4) (2010) 1434–1440].
    Bioorg Med Chem; 2014 Jun; 22(12):3227. PubMed ID: 24955474
    [No Abstract]   [Full Text] [Related]  

  • 13. Commentary to "The structure of McN-5652" [Bioorg. Med. Chem. 9 (2001) 2105] and to the corrigendum to "The structure of McN-5652" [Bioorg. Med. Chem. 10 (2002) 3368].
    Maryanoff BE
    Bioorg Med Chem; 2002 Oct; 10(10):3367. PubMed ID: 12150884
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "Synthesis and biological evaluation of novel benzamide derivatives as potent smoothened antagonists" [Bioorg. Med. Chem. Lett. 24/5 (2014) 1426-1431].
    Wu TM; Wang DC; Xiang P; Zhang JN; Sang YX; Lin HJ; Chen J; Xie G; Song H; Zhao YL; Xie YM
    Bioorg Med Chem Lett; 2016 Sep; 26(18):4558. PubMed ID: 27542309
    [No Abstract]   [Full Text] [Related]  

  • 15. Retraction notice to “Synthesis and biological screening of some novel amidocarbamate derivatives of ketoprofen” [Eur. J. Med. Chem. (2010) 3162-3168].
    Eur J Med Chem; 2012 Jan; 47(1):626. PubMed ID: 22355807
    [No Abstract]   [Full Text] [Related]  

  • 16. Erratum to "Optimization of physicochemical properties of pyridone-based EP3 receptor antagonists" [Bioorg. Med. Chem. Lett. 47 (2021) 128172].
    Zhang X; Zhu B; Guo L; Bakaj I; Rankin M; Ho G; Kauffman J; Lee SP; Norquay L; Macielag M
    Bioorg Med Chem Lett; 2021 Sep; 47():128232. PubMed ID: 34218118
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "Novel salicylanilides from 4,5-dihalogenated salicylic acids: Synthesis, antimicrobial activity and cytotoxicity" [Bioorg. Med. Chem. 25 (2017) 1524-1532].
    Paraskevopoulos G; Monteiro S; Vosátka R; Krátký M; Navrátilová L; Trejtnar F; Stolaříková J; Vinšová J
    Bioorg Med Chem; 2017 Apr; 25(8):2530. PubMed ID: 28285926
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides" [Bioorg. Med. Chem. Lett. 26 (2016) 5867-5870].
    Arslan T; Türkoğlu EA; Şentürk M; Supuran CT
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3944. PubMed ID: 28705642
    [No Abstract]   [Full Text] [Related]  

  • 19. Retraction notice to "Synthesis and biological evaluation of [1,2,4]triazino[4,3-a] benzimidazole acetic acid derivatives as selective aldose reductase inhibitors" [Eur. J. Med. Chem. (2010) 909-914].
    Eur J Med Chem; 2011 Oct; 46(10):5225. PubMed ID: 22049548
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "Synthesis of novel anticancer ruthenium-arene pyridinylmethylene scaffolds via three-component reaction" [Bioorg. Med. Chem. Lett. 26 (2016) 2695-2700].
    Jadhav GR; Sinha S; Chhabra M; Paira P
    Bioorg Med Chem Lett; 2016 Aug; 26(16):4154-4155. PubMed ID: 27396504
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.